Topics

Articles

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond. 

SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener. 

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle. 

New company to be publicly listed as Citius Oncology, Inc.

Investment offers opportunity to expand global footprint, company says. 

Sector is anticipated to grow at a CAGR of 9.3%.